ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Cost of Revenue of $4278.0 for Q1 2026, down 93.8% year-over-year from $68991.0 in Q1 2025, and down 32.74% quarter-over-quarter from $6360.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Cost of Revenue data on file, last reported at $4278.0 in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $4278.0, down 93.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $124757.0 (down 68.92% YoY), and the FY2025 annual result was $189470.0, down 66.82% from the prior year.
- Cost of Revenue declined to $4278.0 in Q1 2026 per NDRA's latest filing, from $6360.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $420439.0 in Q3 2022 and troughed at $4278.0 in Q1 2026.
- A 5-year average of $177323.1 and a median of $162952.0 in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2026: Cost of Revenue jumped 111.21% in 2022, then tumbled 93.8% in 2026.
- A 5-year view of Cost of Revenue shows it stood at $326769.0 in 2022, then plunged by 54.76% to $147833.0 in 2023, then tumbled by 41.64% to $86271.0 in 2024, then slumped by 92.63% to $6360.0 in 2025, then slumped by 32.74% to $4278.0 in 2026.
- Business Quant data shows NDRA's Cost of Revenue at $4278.0 in Q1 2026, $6360.0 in Q4 2025, and $45285.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 155.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 3.26 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 2.36 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 175.25 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 845.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 2.80 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 608,000.00 |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 370.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 118.74 Mn |
| 10 | ENDRA Life Sciences | 5.18 Mn | 4.83 Mn | - | 4,278.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,278.00 |
| Mar 31, 2026 | 4,278.00 |
| Dec 31, 2025 | 6,360.00 |
| Dec 31, 2025 | 6,360.00 |
| Sep 30, 2025 | 45,285.00 |
| Sep 30, 2025 | 45,285.00 |
| Jun 30, 2025 | 68,834.00 |
| Jun 30, 2025 | 68,834.00 |
| Mar 31, 2025 | 68,991.00 |
| Mar 31, 2025 | 68,991.00 |
| Dec 31, 2024 | 86,271.00 |
| Dec 31, 2024 | 86,271.00 |
| Sep 30, 2024 | 83,157.00 |
| Sep 30, 2024 | 83,157.00 |
| Jun 30, 2024 | 162,952.00 |
| Jun 30, 2024 | 162,952.00 |
| Mar 31, 2024 | 238,660.00 |
| Mar 31, 2024 | 238,660.00 |
| Dec 31, 2023 | 147,833.00 |
| Dec 31, 2023 | 147,833.00 |